21ST century cures real world evidence demonstration projects

Ended Awarded Last action

Contract number
75F40118F01011
Awardee
Awarding agency
Obligated
$5,616,500

Award facts

Contract value 100% obligated
$5,616,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Wellesley Hills, Wellesley, MA 02481, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 -$14,500
Other Administrative Action P00011 $0
Terminate for Convenience P00010 · EOI:: GSA wasteful spending ::EOI full termination for convenience $0
Other Administrative Action P00009 · Change COR to craig wright and to change the CO to IAN weiss. $0
Other Administrative Action P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Other Administrative Action P00005 $0
Funding Only Action P00004 $900,000
Supplemental Agreement for work within scope P00003 · Executive order 14042, ensuring adequate covid safety protocols for federal contractors $0
Supplemental Agreement for work within scope P00002 · Extend maintenance and support of the FDA mystudies system to allow its continued use by currently supported pragmatic clinical trials and patient registries… $440,000
Supplemental Agreement for work within scope P00001 · Revise deliverable tables and invoicing $0
Original award $4,291,000
Show all 13

About this award

The Food and Drug Administration issued a delivery order to Harvard Pilgrim Health Care, Inc. on August 30, 2018, with a ceiling value of $5,616,500 for the 21st Century Cures Real World Evidence Demonstration Projects. The order is firm fixed price and was fully terminated for convenience; ultimate completion date was June 3, 2025.

Place of performance is Wellesley Hills, Wellesley, MA. The order carries no set-aside designation. Harvard Pilgrim Health Care, Inc., a non-profit tax-exempt healthcare research organization, operated this delivery order through its Office of Sponsored Programs Division, leveraging its core capability in post-market medical product safety surveillance, pharmacoepidemiology, and real-world evidence research for the FDA.

Quick answers

Who was awarded contract 75F40118F01011?

75F40118F01011 was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 30, 2018.

How much is contract 75F40118F01011 worth?

The government has obligated $5,616,500 on 75F40118F01011.

Is contract 75F40118F01011 an order under another contract?

Yes. 75F40118F01011 is a delivery order under HHSF223201400030I, an indefinite delivery contract.

Was contract 75F40118F01011 competed?

The extent of competition for 75F40118F01011 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award